Nano-X Imaging Ltd. (NNOX)
| Market Cap | 61.20M -82.6% |
| Revenue (ttm) | 14.52M +25.7% |
| Net Income | -76.04M |
| EPS | -1.15 |
| Shares Out | 69.59M |
| PE Ratio | n/a |
| Forward PE | n/a |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 18,151,684 |
| Open | 1.1450 |
| Previous Close | 1.5700 |
| Day's Range | 0.7343 - 1.1800 |
| 52-Week Range | 0.7343 - 5.6900 |
| Beta | 1.17 |
| Analysts | Strong Buy |
| Price Target | 6.53 (+718.74%) |
| Earnings Date | Jun 25, 2026 |
About NNOX
Nano-X Imaging Ltd. develops a commercial-grade tomographic imaging device with a digital X-ray source. It provides teleradiology services and develops artificial intelligence applications to be used in real-world medical imaging applications. The company’s solutions include Nanox Multi Source System comprising Nanox.ARC, a medical tomographic imaging system incorporating its digital X-ray source; and Nanox. CLOUD, a platform which employs a matching engine to match medical images to radiologists that provides image repository, connectivity to ... [Read more]
Financial Performance
In 2025, Nano-X Imaging's revenue was $13.02 million, an increase of 15.40% compared to the previous year's $11.28 million. Losses were -$75.02 million, 40.2% more than in 2024.
Financial StatementsAnalyst Summary
According to 3 analysts, the average rating for NNOX stock is "Strong Buy." The 12-month stock price target is $6.53, which is an increase of 718.74% from the latest price.
News
Nano-X Imaging Earnings Call Transcript: Q1 2026
Revenue grew to $4.3M in Q1 2026, driven by teleradiology and Health IT, but cash burn and commercialization delays led to withdrawal of annual revenue guidance. Multiple new partnerships and restructuring efforts are underway, with a focus on operational milestones and cost control.
Nano-X Imaging Earnings release: Q1 2026
Nano-X Imaging released its Q1 2026 earnings on June 25, 2026, summarizing the period's financial results.
Nano-X Imaging reports Q1 EPS (20c), consensus (14c)
Reports Q1 revenue $4.31M, consensus $4.54M. “To date, we are beginning to see revenue and increased scan utilization from the Nanox.ARC,” said Erez Meltzer, CEO and acting chairman. “We’ve altered…
Nanox Announces First Quarter 2026 Financial Results and Provides Business Updates
PETACH TIKVA, Israel, June 25, 2026 (GLOBE NEWSWIRE) -- NANO-X IMAGING LTD (NASDAQ: NNOX) (“Nanox” or the “Company”), an innovative medical imaging technology company, today announced results for the ...
ROSEN, RECOGNIZED INVESTOR COUNSEL, Encourages Nano-X Imaging Ltd. Investors to Secure Counsel Before Important Deadline in Securities Class - NNOX
New York, New York--(Newsfile Corp. - June 24, 2026) - WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Nano-X Imaging Ltd. (NASDAQ: NNOX) between March 31, ...
Law Offices of Frank R. Cruz Encourages Nano-X Imaging Ltd.
LOS ANGELES--(BUSINESS WIRE)---- $STOCKS--Law Offices of Frank R. Cruz Encourages Nano-X Imaging Ltd. (NNOX) Shareholders To Inquire About Securities Fraud Class Action.
ROSEN, A LONGSTANDING FIRM, Encourages Nano-X Imaging Ltd. Investors to Secure Counsel Before Important Deadline in Securities Class - NNOX
New York, New York--(Newsfile Corp. - June 18, 2026) - WHY: Rosen Law Firm, a global investor rights law firm, announces a class action lawsuit on behalf of purchasers of securities of Nano-X Imaging ...
SueWallSt Reminds Shareholders of a Lead Plaintiff Deadline of August 11, 2026 in Nano-X Imaging Ltd. Lawsuit - NNOX
Important Information Regarding Section 20(a) Individual Liability Claims Against Nano-X Imaging's CEO and CFO for Alleged $33.4 Million Q4 Net Loss NEW YORK, June 18, 2026 /PRNewswire/ -- SueWallSt a...
ROSEN, SKILLED INVESTOR COUNSEL, Encourages Nano-X Imaging Ltd. Investors to Secure Counsel Before Important Deadline in Securities Class - NNOX
New York, New York--(Newsfile Corp. - June 17, 2026) - WHY: Rosen Law Firm, a global investor rights law firm, announces a class action lawsuit on behalf of purchasers of securities of Nano-X Imaging ...
Law Offices of Howard G. Smith Encourages Nano-X Imaging Ltd.
BENSALEM, Pa.--(BUSINESS WIRE)--Law Offices of Howard G. Smith announces that a class action lawsuit has been filed on behalf of investors who purchased Nano-X Imaging Ltd. (“Nano-X” or the “Company”)...
ROSEN, A LEADING INVESTOR RIGHTS LAW FIRM, Encourages Nano-X Imaging Ltd. Investors to Secure Counsel Before Important Deadline in Securities Class – NNOX
NEW YORK, June 16, 2026 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, announces a class action lawsuit on behalf of purchasers of securities of Nano-X Imaging Ltd. (NASDA...
Nanox to Report First Quarter 2026 Financial Results on June 25, 2026
PETACH TIKVA, Israel, June 11, 2026 (GLOBE NEWSWIRE) -- NANO-X IMAGING LTD ("Nanox" or the "Company", Nasdaq: NNOX), an innovative medical imaging technology company, today announced that it will repo...
Nano-X Imaging enters Peruvian market in distribution pact with Top Med
Nanox Imaging announced a distribution agreement with Top Med to deploy the Nanox.ARC system and related services in Peru. Under the agreement, Nanox appointed Top Med as its exclusive distributor…
Exclusive distribution agreement marks Nanox's entry into the Peruvian market
Initial deployment is expected to include six Nanox.ARC systems under a capex model PETACH TIKVA, Israel, June 02, 2026 (GLOBE NEWSWIRE) -- Nanox Imaging Ltd. (“Nanox”, or the “Company” NASDAQ: NNOX),...
Nanox Announces Distribution Agreement with NuvioDx to Support Deployment of Nanox.ARC Systems
Advances Nanox's ongoing U.S. commercialization and deployment efforts PETACH TIKVA, Israel, May 04, 2026 (GLOBE NEWSWIRE) -- Nano X Imaging Ltd. (“Nanox”, or the “Company”, NASDAQ: NNOX), a leader in...
Nano-X Imaging signs distribution agreement with Radiology Oncology Systems
Nano-X Imaging (NNOX) announced that its U.S.-based subsidiary, Nanox Impact, has signed a distribution agreement with Radiology Oncology Systems to distribute its Nanox.ARC systems across the United ...
Nano-X Imaging price target lowered to $5 from $7 at Alliance Global
Alliance Global lowered the firm’s price target on Nano-X Imaging (NNOX) to $5 from $7 and keeps a Buy rating on the shares. The company reported Q4 results that were…
Nano-X Imaging reports Q1 adjusted EPS (17c), consensus (15c)
Reports Q1 revenue $3.72M, consensus $3.99M.
Nano-X Imaging still sees FY26 revenue $35M, cosnensus $31.58M
Nano-X Imaging (NNOX) said: “The Company’s current revenue base remains at an early stage, and the timing and pace of revenue growth are expected to depend primarily on the timing…
Nano-X Imaging announces resignation of CFO Ran Daniel
CFO Ran Daniel has decided to step down from his position, effective July 31, 2026, after five years with the Company. Mr. Daniel will remain with the Company for a…
Nano-X Imaging announces commercial agreement with Howard Technology
Nano-X Imaging (NNOX) announced a strategic commercial agreement with Howard Technology Solutions. The agreement will support the commercial rollout of the Nanox.ARC, an FDA-cleared, multisource digit...
Nano-X Imaging Earnings Call Transcript: Q4 2025
Q4 2025 saw expanded commercial agreements, a strategic acquisition, and a major manufacturing shift, driving a 23% revenue increase year-over-year. The company targets $35M revenue for 2026, with most growth expected in the second half as deployments ramp up.
Nano-X Imaging Earnings release: Q4 2025
Nano-X Imaging released its Q4 2025 earnings on April 20, 2026, summarizing the period's financial results.
Nano-X Imaging Annual report: Q4 2025
Nano-X Imaging has published its Q4 2025 annual report on April 20, 2026.
Nanox.ARC X Digital Advanced 3D imaging built for access and powered by innovation Wins 2026 Red Dot Award for Product Design
International Red Dot Jury recognizes Nanox.ARC X for design excellence that brings advanced 3D tomosynthesis imaging into a wider range of clinical settings